Due to the high gene expression of ERV-K env in ccRCC (Figure 1) and the availability of specific antibodies, a TMA consisting of 374 RCC tissues was implemented to determine the ERV-K env protein expression and localization within cancer cells (Figure 2). This evidence concerns the gene ERVW-1 and renal cell adenocarcinoma.